168 related articles for article (PubMed ID: 38547430)
1. Metabolomics of Multiple Sclerosis Lesions Demonstrates Lipid Changes Linked to Alterations in Transcriptomics-Based Cellular Profiles.
Ladakis DC; Pedrini E; Reyes-Mantilla MI; Sanjayan M; Smith MD; Fitzgerald KC; Pardo CA; Reich DS; Absinta M; Bhargava P
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200219. PubMed ID: 38547430
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Multi-Omics Map of Cell Type-Specific Mechanistic Drivers of Multiple Sclerosis Lesions.
Elkjaer ML; Hartebrodt A; Oubounyt M; Weber A; Vitved L; Reynolds R; Thomassen M; Rottger R; Baumbach J; Illes Z
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200213. PubMed ID: 38564686
[TBL] [Abstract][Full Text] [Related]
3. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
4. Effects of Pregnancy on Plasma Sphingolipids Using a Metabolomic and Quantitative Analysis Approach.
Enthoven LF; Shi Y; Fay E; Kim A; Moreni S; Mao J; Isoherranen N; Totah RA; Hebert MF
Metabolites; 2023 Sep; 13(9):. PubMed ID: 37755306
[TBL] [Abstract][Full Text] [Related]
5. Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue.
Aragón-Herrera A; Feijóo-Bandín S; Abella V; Álvarez L; Roselló-Lletí E; Portolés M; Tarazón E; Bigazzi M; Bani D; Gualillo O; González-Juanatey JR; Lago F
Pharmacol Res; 2019 Jun; 144():51-65. PubMed ID: 30954631
[TBL] [Abstract][Full Text] [Related]
6. Several serum lipid metabolites are associated with relapse risk in pediatric-onset multiple sclerosis.
Virupakshaiah A; Ladakis DC; Nourbakhsh B; Bhargava P; Dilwali S; Schoeps V; Borkowski K; Newman JW; Waubant E
Mult Scler; 2023 Jul; 29(8):936-944. PubMed ID: 37199529
[TBL] [Abstract][Full Text] [Related]
7. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis.
Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262
[TBL] [Abstract][Full Text] [Related]
8. Alterations of host-gut microbiome interactions in multiple sclerosis.
Cantoni C; Lin Q; Dorsett Y; Ghezzi L; Liu Z; Pan Y; Chen K; Han Y; Li Z; Xiao H; Gormley M; Liu Y; Bokoliya S; Panier H; Suther C; Evans E; Deng L; Locca A; Mikesell R; Obert K; Newland P; Wu Y; Salter A; Cross AH; Tarr PI; Lovett-Racke A; Piccio L; Zhou Y
EBioMedicine; 2022 Feb; 76():103798. PubMed ID: 35094961
[TBL] [Abstract][Full Text] [Related]
9. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
10. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients.
Solmaz İ; Kaplan O; Çelebier M; Lay İ; Anlar B
Turk J Med Sci; 2022 Aug; 52(4):1299-1310. PubMed ID: 36326407
[TBL] [Abstract][Full Text] [Related]
11. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
Guo M; Zhang J
Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
[TBL] [Abstract][Full Text] [Related]
12. Expression of disease-related miRNAs in white-matter lesions of progressive multiple sclerosis brains.
Tripathi A; Volsko C; Datta U; Regev K; Dutta R
Ann Clin Transl Neurol; 2019 May; 6(5):854-862. PubMed ID: 31139683
[TBL] [Abstract][Full Text] [Related]
13. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
Li J; Liu D; Cui M; Wei Z
J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling suggests long chain ceramides and sphingomyelins as a possible diagnostic biomarker of epithelial ovarian cancer.
Kozar N; Kruusmaa K; Bitenc M; Argamasilla R; Adsuar A; Goswami N; Arko D; Takač I
Clin Chim Acta; 2018 Jun; 481():108-114. PubMed ID: 29481776
[TBL] [Abstract][Full Text] [Related]
15. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
Bodini B; Poirion E; Tonietto M; Benoit C; Palladino R; Maillart E; Portera E; Battaglini M; Bera G; Kuhnast B; Louapre C; Bottlaender M; Stankoff B
J Nucl Med; 2020 Jul; 61(7):1043-1049. PubMed ID: 32005777
[TBL] [Abstract][Full Text] [Related]
16. Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults.
Bagheri M; Djazayery A; Farzadfar F; Qi L; Yekaninejad MS; Aslibekyan S; Chamari M; Hassani H; Koletzko B; Uhl O
Lipids Health Dis; 2019 Apr; 18(1):94. PubMed ID: 30967146
[TBL] [Abstract][Full Text] [Related]
17. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
[TBL] [Abstract][Full Text] [Related]
18. The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Singhal NK; Huang H; Li S; Clements R; Gadd J; Daniels A; Kooijman EE; Bannerman P; Burns T; Guo F; Pleasure D; Freeman E; Shriver L; McDonough J
Exp Brain Res; 2017 Jan; 235(1):279-292. PubMed ID: 27709268
[TBL] [Abstract][Full Text] [Related]
19. Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?
Boscia F; Elkjaer ML; Illes Z; Kukley M
Front Cell Neurosci; 2021; 15():685703. PubMed ID: 34276310
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
